EurekAlert! National Institutes of Health

Latest news releases from NIH-funded organizations

Funded Research News

Updates every hour. Last Updated: 27-Apr-2025 22:08 ET (28-Apr-2025 02:08 GMT/UTC)

14-Nov-2024

Drug combination prompts immune response in some resistant pancreatic cancers

Johns Hopkins Medicine
Peer-Reviewed Publication

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

Journal: Nature Communications
Funder: Lustgarten Foundation’s Research Investigator Program, National Cancer Institute, NIH/National Institutes of Health, MD Anderson Cancer Center SPORE in Gastrointestinal Cancer – The Career Enhancement Program, Maryland Cancer Moonshot Research

14-Nov-2024

Novel SOURCE study examining development of early COPD in ages 30 to 55

COPD Foundation
Peer-Reviewed Publication

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.

Journal: Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
Funder: NIH/National Heart, Lung and Blood Institute, Amgen, AstraZeneca, MedImmune, Bayer, Bellerophon Therapeutics, Boehringer Ingelheim, Chiesi Farmaceutici, Forest Research Institute, Genentech, GlaxoSmithKline, Grifols, Ikaria, MGC Diagnostics, Novartis Pharma, Nycomed GmbH, ProterixBio, Regeneron Pharmaceuticals, Sanofi, Sunovion, Takeda Pharmaceutical Company, Theravance Biopharma US, Mylan, Viatris

14-Nov-2024

New roles in infectious process for molecule that inhibits flu

Ohio State University
Peer-Reviewed Publication

Researchers have identified new roles for a protein long known to protect against severe flu infection – among them, raising the minimum number of viral particles needed to cause sickness.

Journal: Nature Communications
Funder: NIH/National Institutes of Health

13-Nov-2024

Vaccine shows promise against aggressive breast cancer

WashU Medicine
Peer-Reviewed Publication

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a neoantigen DNA vaccine — for breast cancer patients.

Journal: Genome Medicine
Funder: NIH/National Institutes of Health

13-Nov-2024

Huntington’s disease gene also enhances early brain development and intelligence

University of Iowa Health Care
Peer-Reviewed Publication

The Huntington’s disease (HD) mutation eventually causes a fatal brain disease in adulthood, but a University of Iowa study finds that early in life, children with the HD mutation have bigger brains and higher IQ than children without the mutation.

Journal: Annals of Neurology
Funder: NIH/National Institute of Neurological Disorders and Stroke, CHDI Foundation